BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32501471)

  • 1. Siglec-15 recognition of sialoglycans on tumor cell lines can occur independently of sialyl Tn antigen expression.
    Murugesan G; Correia VG; Palma AS; Chai W; Li C; Feizi T; Martin E; Laux B; Franz A; Fuchs K; Weigle B; Crocker PR
    Glycobiology; 2021 Jan; 31(1):44-54. PubMed ID: 32501471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction between Siglec-15 and tumor-associated sialyl-Tn antigen enhances TGF-β secretion from monocytes/macrophages through the DAP12-Syk pathway.
    Takamiya R; Ohtsubo K; Takamatsu S; Taniguchi N; Angata T
    Glycobiology; 2013 Feb; 23(2):178-87. PubMed ID: 23035012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2-6 sialic acids.
    Loureiro LR; Sousa DP; Ferreira D; Chai W; Lima L; Pereira C; Lopes CB; Correia VG; Silva LM; Li C; Santos LL; Ferreira JA; Barbas A; Palma AS; Novo C; Videira PA
    Sci Rep; 2018 Aug; 8(1):12196. PubMed ID: 30111774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New aspects of siglec binding specificities, including the significance of fucosylation and of the sialyl-Tn epitope. Sialic acid-binding immunoglobulin superfamily lectins.
    Brinkman-Van der Linden EC; Varki A
    J Biol Chem; 2000 Mar; 275(12):8625-32. PubMed ID: 10722702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning and characterization of Siglec-10, a novel sialic acid binding member of the Ig superfamily, from human dendritic cells.
    Li N; Zhang W; Wan T; Zhang J; Chen T; Yu Y; Wang J; Cao X
    J Biol Chem; 2001 Jul; 276(30):28106-12. PubMed ID: 11358961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathways of mucin O-glycosylation in normal and malignant rat colonic epithelial cells reveal a mechanism for cancer-associated Sialyl-Tn antigen expression.
    Brockhausen I; Yang J; Lehotay M; Ogata S; Itzkowitz S
    Biol Chem; 2001 Feb; 382(2):219-32. PubMed ID: 11308020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing the cis interactions of the inhibitory receptor Siglec-7 with alpha2,8-disialylated ligands on natural killer cells and other leukocytes using glycan-specific antibodies and by analysis of alpha2,8-sialyltransferase gene expression.
    Avril T; North SJ; Haslam SM; Willison HJ; Crocker PR
    J Leukoc Biol; 2006 Oct; 80(4):787-96. PubMed ID: 16857734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Sialyl-Tn in Cancer.
    Munkley J
    Int J Mol Sci; 2016 Feb; 17(3):275. PubMed ID: 26927062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer.
    Sewell R; Bäckström M; Dalziel M; Gschmeissner S; Karlsson H; Noll T; Gätgens J; Clausen H; Hansson GC; Burchell J; Taylor-Papadimitriou J
    J Biol Chem; 2006 Feb; 281(6):3586-94. PubMed ID: 16319059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6'-sulfo-sialyl Lewis X as a preferred glycan ligand.
    Tateno H; Crocker PR; Paulson JC
    Glycobiology; 2005 Nov; 15(11):1125-35. PubMed ID: 15972893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of the sialic acid/Siglec-9 axis improves antibody-mediated neutrophil cytotoxicity towards tumor cells.
    Lustig M; Chan C; Jansen JHM; Bräutigam M; Kölling MA; Gehlert CL; Baumann N; Mester S; Foss S; Andersen JT; Bastian L; Sondermann P; Peipp M; Burger R; Leusen JHW; Valerius T
    Front Immunol; 2023; 14():1178817. PubMed ID: 37346044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-glycans on death receptors in cells modulate their sensitivity to TRAIL-induced apoptosis through affecting on their stability and oligomerization.
    Jiang Y; Wen T; Yan R; Kim SR; Stowell SR; Wang W; Wang Y; An G; Cummings RD; Ju T
    FASEB J; 2020 Sep; 34(9):11786-11801. PubMed ID: 32692906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of the sialic acid-binding lectin, Siglec-9, to the membrane mucin, MUC1, induces recruitment of β-catenin and subsequent cell growth.
    Tanida S; Akita K; Ishida A; Mori Y; Toda M; Inoue M; Ohta M; Yashiro M; Sawada T; Hirakawa K; Nakada H
    J Biol Chem; 2013 Nov; 288(44):31842-52. PubMed ID: 24045940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular structure, expression, and the emerging role of Siglec-15 in skeletal biology and cancer.
    Rashid S; Song D; Yuan J; Mullin BH; Xu J
    J Cell Physiol; 2022 Mar; 237(3):1711-1719. PubMed ID: 34893976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engagement of sialylated glycans with Siglec receptors on suppressive myeloid cells inhibits anticancer immunity via CCL2.
    Wieboldt R; Sandholzer M; Carlini E; Lin CW; Börsch A; Zingg A; Lardinois D; Herzig P; Don L; Zippelius A; Läubli H; Mantuano NR
    Cell Mol Immunol; 2024 May; 21(5):495-509. PubMed ID: 38448555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycan elongation beyond the mucin associated Tn antigen protects tumor cells from immune-mediated killing.
    Madsen CB; Lavrsen K; Steentoft C; Vester-Christensen MB; Clausen H; Wandall HH; Pedersen AE
    PLoS One; 2013; 8(9):e72413. PubMed ID: 24039759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling Molecular Recognition of Glycan Ligands by Siglec-9 via NMR Spectroscopy and Molecular Dynamics Modeling.
    Atxabal U; Nycholat C; Pröpster JM; Fernández A; Oyenarte I; Lenza MP; Franconetti A; Soares CO; Coelho H; Marcelo F; Schubert M; Paulson JC; Jiménez-Barbero J; Ereño-Orbea J
    ACS Chem Biol; 2024 Feb; 19(2):483-496. PubMed ID: 38321945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sialoglycans on lymphatic endothelial cells augment interactions with Siglec-1 (CD169) of lymph node macrophages.
    D'Addio M; Frey J; Tacconi C; Commerford CD; Halin C; Detmar M; Cummings RD; Otto VI
    FASEB J; 2021 Nov; 35(11):e22017. PubMed ID: 34699642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Siglec Signaling in the Tumor Microenvironment.
    van Houtum EJH; Büll C; Cornelissen LAM; Adema GJ
    Front Immunol; 2021; 12():790317. PubMed ID: 34966391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OB-BP1/Siglec-6. a leptin- and sialic acid-binding protein of the immunoglobulin superfamily.
    Patel N; Brinkman-Van der Linden EC; Altmann SW; Gish K; Balasubramanian S; Timans JC; Peterson D; Bell MP; Bazan JF; Varki A; Kastelein RA
    J Biol Chem; 1999 Aug; 274(32):22729-38. PubMed ID: 10428856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.